Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
Revista
País de afiliación
Intervalo de año de publicación
1.
AANA J ; 76(6): 425-31, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19090310

RESUMEN

Endotracheal intubation (ETT) can cause emergence phenomena (EP) including coughing, sore throat, and dysphonia. Two methods used to prevent EP are the administration of local anesthetics directly onto airway structures using a specialized laryngotracheal instillation of topical anesthesia (LITA) tube (Sheridan Catheter Corporation, Argyle, New York) or the placement of a local anesthetic into the ETT cuff. The purpose of this study was to determine which method was better at preventing ERl In this prospective, randomized, comparative analysis, a sample of 160 ASA class I through III patients were randomly assigned to receive their EP prophylaxes either by placement of alkalinized lidocaine directly into the ETT cuff at intubation or by injection into a specialized port on the LITA tube approximately 30 minutes before extubation. Variables measured included the incidence and severity of sore throat, coughing, and dysphonia for the first 24 hours following surgery. The incidence of cough and sore throat was higher in the LITA group, achieving significance in the postanesthesia care unit and after discharge to home. No difference in any of the other variables was noted between groups. Our study demonstrated greater efficacy in decreasing the incidence and severity of EP by placing an alkalinized solution of lidocaine into the ETT cuff on intubation.


Asunto(s)
Anestesia/métodos , Anestésicos Locales/administración & dosificación , Tos/prevención & control , Disfonía/prevención & control , Intubación Intratraqueal/métodos , Lidocaína/administración & dosificación , Faringitis/prevención & control , Complicaciones Posoperatorias/prevención & control , Adulto , Anestesia/efectos adversos , Femenino , Humanos , Intubación Intratraqueal/efectos adversos , Masculino , Estudios Prospectivos
2.
AANA J ; 75(1): 27-33, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17304780

RESUMEN

Postoperative nausea and vomiting (PONV) is prevalent in surgical patients with known risk factors: general anesthesia, female, nonsmoker, motion sickness history, and PONV history. Common treatment involves ondansetron; however, the effects are short-lived, and supplemental medication may be required. Meclizine, a long-acting drug with a low side-effect profile, may be ideal in combination with ondansetron for at-risk patients. We randomized 77 subjects scheduled for general anesthesia and screened for 4 of 5 PONV risk factors for experimental or control group assignment. Severity of PONV was measured using a 0 to 10 verbal numeric rating scale (VNRS). Other measured variables included time to onset and incidence of PONV and total antiemetic requirements. No significant differences in demographics (excluding weight), surgical or anesthesia time, analgesic requirements, or nausea incidence in the postanesthesia care unit (PACU) and same-day surgery unit were noted. The meclizine group had lower VNRS scores in the PACU at 15 (P = .013) and 45 (P = .006) minutes following rescue treatment. The incidence of nausea was lower in the meclizine vs. placebo group (10% vs. 29%) following discharge (P = .038). Prophylactic meclizine resulted in lower incidence and severity of PONV in a high-risk population, especially after rescue treatment.


Asunto(s)
Meclizina/uso terapéutico , Náusea/prevención & control , Ondansetrón/uso terapéutico , Complicaciones Posoperatorias/prevención & control , Vómitos/prevención & control , Adulto , Quimioterapia Combinada , Procedimientos Quirúrgicos Electivos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Mareo por Movimiento/epidemiología , Medición de Riesgo
3.
AANA J ; 74(3): 201-6, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16786913

RESUMEN

We conducted a prospective, randomized study to compare differences between groups of patients given a brachial plexus block using an interscalene (IS) or an intersternocleidomastoid (ISCM) approach. Specific variables analyzed included overall success rates, time to achieve sensory and motor anesthesia, time to place block, and incidence of side effects. For the study, 81 patients were randomized to receive a brachial plexus blockade using the IS or ISCM approach followed by general anesthesia for their surgical procedure. Intraoperative analgesics were controlled for in both groups. No differences in demographics, block success rate, pain scale scores, and analgesia duration were noted between groups. The ISCM group required less time to complete the block (7.08 +/- 2.9 min) compared with the IS group (9.62 +/- 5.31 min) (P = .039), achieved a significantly higher rate of complete motor and sensory block at 30 minutes (P = .032), and had fewer side effects (P = .049). Based on our results, we found that using the ISCM approach to the brachial plexus resulted in a faster onset of anesthesia and a higher ratio of complete block at 30 minutes compared with the IS approach.


Asunto(s)
Plexo Braquial , Músculos Intercostales , Músculos del Cuello , Bloqueo Nervioso/métodos , Adolescente , Adulto , Anciano , Anestesia General , Anestésicos Locales , Brazo/inervación , Brazo/cirugía , Síndrome de Horner/inducido químicamente , Humanos , Mepivacaína , Persona de Mediana Edad , Bloqueo Nervioso/efectos adversos , Dimensión del Dolor , Dolor Postoperatorio/diagnóstico , Dolor Postoperatorio/etiología , Dolor Postoperatorio/psicología , Satisfacción del Paciente , Estudios Prospectivos , Parálisis Respiratoria/inducido químicamente , Posición Supina , Tetracaína , Factores de Tiempo , Resultado del Tratamiento , Parálisis de los Pliegues Vocales/inducido químicamente
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA